{"product_id":"havrix-ped-jeringa-0-5ml-con-1-vacuna-antihepatitis-a","title":"Havrix Ped Syringe 0.5mL with 1 (Hepatitis A Vaccine)","description":"\u003ch2\u003eCategory\u003c\/h2\u003e\n\u003cp\u003eVaccine\u003c\/p\u003e\n\n\u003ch2\u003eLine\u003c\/h2\u003e\n\u003cp\u003eHepatitis A Vaccine\u003c\/p\u003e\n\n\u003ch2\u003eBrand\u003c\/h2\u003e\n\u003cp\u003eHavrix\u003c\/p\u003e\n\n\u003ch2\u003eMolecule\u003c\/h2\u003e\n\u003cp\u003eInactivated Anti-hepatitis A Immunoglobulin\u003c\/p\u003e\n\n\u003ch2\u003ePresentation\u003c\/h2\u003e\n\u003cp\u003e0.5 mL Syringe\u003c\/p\u003e\n\n\u003ch2\u003eLaboratory\u003c\/h2\u003e\n\u003cp\u003eGlaxo Smith Kline\u003c\/p\u003e\n\n\u003ch2\u003eIndications\u003c\/h2\u003e\n\u003cp\u003eHavrix Ped is indicated for active immunization against hepatitis A in children aged 12 months and older. The vaccine stimulates the production of specific antibodies against the hepatitis A virus, providing protection against infection. It is recommended to administer the vaccine to children in areas of high hepatitis A endemicity or who are at risk of exposure to the virus, such as those traveling to regions where hepatitis A is common. Additionally, vaccination is suggested for individuals with conditions that increase the risk of infection, such as those with chronic liver diseases or who are receiving immunosuppressive treatment.\u003c\/p\u003e\n\n\u003ch2\u003eComposition\u003c\/h2\u003e\n\u003cp\u003eEach 0.5 mL syringe of Havrix Ped contains: \n\u003c\/p\u003e\u003cul\u003e\n    \u003cli\u003eInactivated hepatitis A virus\u003c\/li\u003e\n    \u003cli\u003eExcipients: sodium phosphate, sodium chloride, and water for injection.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\n\u003ch2\u003eContraindications\u003c\/h2\u003e\n\u003cp\u003eHavrix Ped should not be administered in the following cases:\n\u003c\/p\u003e\u003cul\u003e\n    \u003cli\u003eIn patients with known hypersensitivity to any component of the vaccine.\u003c\/li\u003e\n    \u003cli\u003eIn individuals who have had a severe adverse reaction to previous doses of the vaccine.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\n\u003ch2\u003ePrecautions\u003c\/h2\u003e\n\u003cp\u003eSpecial care should be taken in patients with acute febrile illness or moderate to severe infections. Vaccination should be postponed until recovery. Additionally, the patient's medical history should be evaluated to identify possible adverse reactions. It is important to inform about the possibility of side effects and the need to observe the patient after vaccination.\u003c\/p\u003e\n\n\u003ch2\u003eStorage\u003c\/h2\u003e\n\u003cp\u003eHavrix Ped should be stored refrigerated (2°C to 8°C). Do not freeze. Keep out of reach of children. Check the expiration date before administration.\u003c\/p\u003e\n\n\u003cp\u003ePrescription required.\u003c\/p\u003e\n\u003cp\u003eConsult your doctor.\u003c\/p\u003e","brand":"Glaxo Smith Kline","offers":[{"title":"Default Title","offer_id":45848298062049,"sku":"7501064551512","price":1142.86,"currency_code":"MXN","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0722\/1500\/3361\/files\/7501064551512_491faef8-364b-4d0c-9f22-52ffe4306abb.jpg?v=1744677084","url":"https:\/\/wecarepharma.mx\/en\/products\/havrix-ped-jeringa-0-5ml-con-1-vacuna-antihepatitis-a","provider":"WeCare Pharma","version":"1.0","type":"link"}